{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:29:23Z","timestamp":1770726563331,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yijishan Hospital Affiliated to Wannan Medical College","award":["KPF2019011"],"award-info":[{"award-number":["KPF2019011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04170-w","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:53:59Z","timestamp":1768298039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circular RNA hsa_circ_0001829 promotes pancreatic ductal adenocarcinoma through miR-7113\u20133p\/DTX4 axis"],"prefix":"10.1186","volume":"24","author":[{"given":"Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"1","key":"4170_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12951-022-01382-0","volume":"20","author":"Y Li","year":"2022","unstructured":"Li Y, Zhao W, Wang Y, Wang H, Liu S. Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment. J Nanobiotechnol. 2022;20(1):208.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4170_CR2","doi-asserted-by":"publisher","first-page":"5941","DOI":"10.1038\/s41467-022-33718-7","volume":"13","author":"JT Topham","year":"2022","unstructured":"Topham JT, Tsang ES, Karasinska JM, Metcalfe A, Ali H, Kalloger SE, Csizmok V, Williamson LM, Titmuss E, Nielsen K, Negri GL, Spencer Miko SE, Jang GH, Denroche RE, Wong HL, O\u2019Kane GM, Moore RA, Mungall AJ, Loree JM, Notta F, Wilson JM, Bathe OF, Tang PA, Goodwin R, Morin GB, Knox JJ, Gallinger S, Laskin J, Marra MA, Jones SJM, Schaeffer DF, Renouf DJ. Integrative analysis of KRAS wildtype metastatic pancreatic ductal adenocarcinoma reveals mutation and expression-based similarities to cholangiocarcinoma. Nat Commun. 2022;13(1):5941.","journal-title":"Nat Commun"},{"issue":"1","key":"4170_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12943-023-01727-9","volume":"22","author":"Z Yang","year":"2023","unstructured":"Yang Z, Zhou L, Si T, Chen S, Liu C, Ng KK, Wang Z, Chen Z, Qiu C, Liu G, Wang Q, Zhou X, Zhang L, Yao Z, He S, Yang M, Zhou Z. Lysyl hydroxylase LH1 promotes confined migration and metastasis of cancer cells by stabilizing Septin2 to enhance actin network. Mol Cancer. 2023;22(1):21.","journal-title":"Mol Cancer"},{"issue":"4","key":"4170_CR4","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/15384101.2021.2020450","volume":"21","author":"W Liu","year":"2022","unstructured":"Liu W, Deng L, Xu A, Xiong X, Tao J, Chang J, Xu Y, Zhou Z. Identifying a novel IRF3\/circUHRF1\/miR-1306-5p\/ARL4C axis in pancreatic ductal adenocarcinoma progression. Cell Cycle. 2022;21(4):392\u2013405.","journal-title":"Cell Cycle"},{"issue":"27","key":"4170_CR5","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3748\/wjg.v28.i27.3297","volume":"28","author":"C Smith","year":"2022","unstructured":"Smith C, Zheng W, Dong J, Wang Y, Lai J, Liu X, Yin F. Tumor microenvironment in pancreatic ductal adenocarcinoma: implications in immunotherapy. World J Gastroenterol. 2022;28(27):3297\u2013313.","journal-title":"World J Gastroenterol"},{"key":"4170_CR6","doi-asserted-by":"publisher","first-page":"1163585","DOI":"10.3389\/fimmu.2023.1163585","volume":"14","author":"LN Strickland","year":"2023","unstructured":"Strickland LN, Faraoni EY, Ruan W, Yuan X, Eltzschig HK, Bailey-Lundberg JM. The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer. Front Immunol. 2023;14:1163585.","journal-title":"Front Immunol"},{"issue":"1","key":"4170_CR7","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13104-024-06757-0","volume":"17","author":"T Araki","year":"2024","unstructured":"Araki T, Miwa N. Selective epigenetic alterations in RNF43 in pancreatic exocrine cells from high-fat-diet-induced obese mice; implications for pancreatic cancer. BMC Res Notes. 2024;17(1):106.","journal-title":"BMC Res Notes"},{"issue":"6","key":"4170_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.stem.2021.03.005","volume":"28","author":"M Breunig","year":"2021","unstructured":"Breunig M, Merkle J, Wagner M, Melzer MK, Barth TFE, Engleitner T, et al. Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells. Cell Stem Cell. 2021;28(6):1105\u201324.","journal-title":"Cell Stem Cell"},{"issue":"7","key":"4170_CR9","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1245\/s10434-025-17281-1","volume":"32","author":"AB Blair","year":"2025","unstructured":"Blair AB, Zheng L, Soares KC. The landmark series: therapeutic cancer vaccine strategies for cold tumors. Ann Surg Oncol. 2025;32(7):4957\u201366.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4170_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12672-024-01548-2","volume":"15","author":"Z Xiao","year":"2024","unstructured":"Xiao Z, Liu X, Wang Y, Jiang S, Feng Y. Comprehensive analysis of single-cell and bulk RNA sequencing reveals postoperative progression markers for non-muscle invasive bladder cancer and predicts responses to immunotherapy. Discov Oncol. 2024;15(1):649.","journal-title":"Discov Oncol"},{"key":"4170_CR11","doi-asserted-by":"publisher","first-page":"1130472","DOI":"10.3389\/fonc.2023.1130472","volume":"13","author":"D Zhu","year":"2023","unstructured":"Zhu D, Ouyang X, Zhang Y, Yu X, Su K, Li L. A promising new cancer marker: long noncoding RNA EGFR-AS1. Front Oncol. 2023;13:1130472.","journal-title":"Front Oncol"},{"issue":"1","key":"4170_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-020-01279-2","volume":"19","author":"W Gao","year":"2020","unstructured":"Gao W, Guo H, Niu M, Zheng X, Zhang Y, Xue X, et al. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Mol Cancer. 2020;19(1):166.","journal-title":"Mol Cancer"},{"issue":"1","key":"4170_CR13","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12967-025-06463-w","volume":"23","author":"H Yin","year":"2025","unstructured":"Yin H, Shi J, Li S, You Q, Zhu H, Koo C, Liu B, Hou L, Wu C. Emerging roles of Exosomal circrnas in non-small cell lung cancer. J Transl Med. 2025;23(1):490.","journal-title":"J Transl Med"},{"issue":"4","key":"4170_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.trecan.2020.01.012","volume":"6","author":"J Li","year":"2020","unstructured":"Li J, Sun D, Pu W, Wang J, Peng Y. Circular RNAs in cancer: Biogenesis, Function, and clinical significance. Trends Cancer. 2020;6(4):319\u201336.","journal-title":"Trends Cancer"},{"issue":"3","key":"4170_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","volume":"19","author":"LS Kristensen","year":"2022","unstructured":"Kristensen LS, Jakobsen T, Hager H, Kjems J. The emerging roles of circrnas in cancer and oncology. Nat Reviews Clin Oncol. 2022;19(3):188\u2013206.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"1","key":"4170_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12943-025-02467-8","volume":"24","author":"Z Han","year":"2025","unstructured":"Han Z, Liu W, Zhu Y, Sun Y, Sun D, Jia R, Yang Y, Qi H, Zhang L, Huo Y, Zhang N, Chai J, Yang M. Non-coding RNAs in gastric cancer: mechanisms and therapeutic prospects. Mol Cancer. 2025;24(1):244.","journal-title":"Mol Cancer"},{"issue":"1","key":"4170_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-025-02259-0","volume":"24","author":"X Du","year":"2025","unstructured":"Du X, Luo W, Li H, Gu Q, Huang P, Wang C, Li N, Liu F, Xia C. Hsa_circ_0125356 promotes gemcitabine resistance by modulating WNT canonical and non-canonical pathways via miR-582-5p\/FGF9 axis in non-small cell lung cancer. Mol Cancer. 2025;24(1):59.","journal-title":"Mol Cancer"},{"issue":"4","key":"4170_CR18","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/hep.31493","volume":"73","author":"Y Xu","year":"2021","unstructured":"Xu Y, Leng K, Yao Y, Kang P, Liao G, Han Y, et al. A circular RNA, cholangiocarcinoma-Associated circular RNA 1, contributes to cholangiocarcinoma Progression, induces Angiogenesis, and disrupts vascular endothelial barriers. Hepatology (Baltimore MD). 2021;73(4):1419\u201335.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"4170_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12943-022-01599-5","volume":"21","author":"L Meng","year":"2022","unstructured":"Meng L, Zhang Y, Wu P, Li D, Lu Y, Shen P, et al. CircSTX6 promotes pancreatic ductal adenocarcinoma progression by sponging miR-449b-5p and interacting with CUL2. Mol Cancer. 2022;21(1):121.","journal-title":"Mol Cancer"},{"issue":"1","key":"4170_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s13046-020-01790-w","volume":"39","author":"Q Niu","year":"2020","unstructured":"Niu Q, Dong Z, Liang M, Luo Y, Lin H, Lin M, et al. Circular RNA hsa_circ_0001829 promotes gastric cancer progression through miR-155-5p\/SMAD2 axis. J Experimental Clin Cancer Research: CR. 2020;39(1):280.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"1","key":"4170_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12859-022-04705-y","volume":"23","author":"S Zhong","year":"2022","unstructured":"Zhong S, Feng J. CircPrimer 2.0: a software for annotating circrnas and predicting translation potential of circrnas. BMC Bioinformatics. 2022;23(1):215.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"4170_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are MicroRNA targets. Cell. 2005;120(1):15\u201320.","journal-title":"Cell"},{"issue":"26","key":"4170_CR23","doi-asserted-by":"publisher","first-page":"22754","DOI":"10.1021\/acsomega.2c02277","volume":"7","author":"F Ali","year":"2022","unstructured":"Ali F, Khan A, Muhammad SA, Abbas SQ, Hassan SSU, Bungau S. Genome-wide Meta-analysis reveals new gene signatures and potential drug targets of hypertension. ACS Omega. 2022;7(26):22754\u201372.","journal-title":"ACS Omega"},{"issue":"1","key":"4170_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37(1):1\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"4170_CR25","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. MiRDB: an online database for prediction of functional MicroRNA targets. Nucleic Acids Res. 2020;48(D1):D127\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"6472","key":"4170_CR26","doi-asserted-by":"publisher","first-page":"eaav1741","DOI":"10.1126\/science.aav1741","volume":"366","author":"SE McGeary","year":"2019","unstructured":"McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, et al. The biochemical basis of MicroRNA targeting efficacy. Sci (New York NY). 2019;366(6472):eaav1741.","journal-title":"Sci (New York NY)"},{"issue":"W1","key":"4170_CR27","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"C Li","year":"2021","unstructured":"Li C, Tang Z, Zhang W, Ye Z, Liu F. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49(W1):W242\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4170_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12943-020-01205-6","volume":"19","author":"Y Kong","year":"2020","unstructured":"Kong Y, Li Y, Luo Y, Zhu J, Zheng H, Gao B, et al. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p\/PIK3R1\/VEGF-C axis in pancreatic cancer. Mol Cancer. 2020;19(1):82.","journal-title":"Mol Cancer"},{"issue":"1","key":"4170_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12943-022-01501-3","volume":"21","author":"C Hu","year":"2022","unstructured":"Hu C, Xia R, Zhang X, Li T, Ye Y, Li G, et al. circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF\/STAT3 axis. Mol Cancer. 2022;21(1):24.","journal-title":"Mol Cancer"},{"issue":"1","key":"4170_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-020-01196-4","volume":"19","author":"X Guo","year":"2020","unstructured":"Guo X, Zhou Q, Su D, Luo Y, Fu Z, Huang L, et al. Circular RNA circbfar promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p\/MET\/Akt axis. Mol Cancer. 2020;19(1):83.","journal-title":"Mol Cancer"},{"issue":"1","key":"4170_CR31","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s12672-025-02902-8","volume":"16","author":"M Li","year":"2025","unstructured":"Li M, Cheng Y, Qiu F, Mu X, Zhai P, Li Z, Liu Q, Li Q. LncRNA EBLN3P\/microRNA-323a-3p\/EphA1 axis affects the biological function of hepatocellular carcinoma cells. Discov Oncol. 2025;16(1):1145.","journal-title":"Discov Oncol"},{"issue":"4","key":"4170_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ni.2239","volume":"13","author":"J Cui","year":"2012","unstructured":"Cui J, Li Y, Zhu L, Liu D, Songyang Z, Wang HY, et al. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat Immunol. 2012;13(4):387\u201395.","journal-title":"Nat Immunol"},{"issue":"4","key":"4170_CR33","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s11033-009-9614-3","volume":"37","author":"WM Liu","year":"2010","unstructured":"Liu WM, Laux H, Henry JY, Bolton TB, Dalgleish AG, Galustian C. A microarray study of altered gene expression in colorectal cancer cells after treatment with Immunomodulatory drugs: differences in action in vivo and in vitro. Mol Biol Rep. 2010;37(4):1801\u201314.","journal-title":"Mol Biol Rep"},{"key":"4170_CR34","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.12659\/MSM.896047","volume":"22","author":"M Liu","year":"2016","unstructured":"Liu M, Zhu K, Qian X, Li W. Identification of miRNA\/mRNA-Negative regulation pairs in nasopharyngeal carcinoma. Med Sci Monitor: Int Med J Experimental Clin Res. 2016;22:2215\u201334.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"9","key":"4170_CR35","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24(9):597\u2013613.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4170_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13045-023-01452-2","volume":"16","author":"F Zhang","year":"2023","unstructured":"Zhang F, Jiang J, Qian H, Yan Y, Xu W. Exosomal circrna: emerging insights into cancer progression and clinical application potential. J Hematol Oncol. 2023;16(1):67.","journal-title":"J Hematol Oncol"},{"key":"4170_CR37","doi-asserted-by":"crossref","unstructured":"Li J, Li Z, Jiang P, Peng M, Zhang X, Chen K Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis. Journal of experimentalclinical cancer research: CR., Xia X, Li X, Li F, Wu X, Zhang M, Zhou H et al. Correction: A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent Kinase-1. Molecular cancer. 2022;21(1):124.","DOI":"10.1186\/s12943-022-01584-y"},{"key":"4170_CR38","doi-asserted-by":"publisher","first-page":"706997","DOI":"10.3389\/fcell.2021.706997","volume":"9","author":"L Wang","year":"2021","unstructured":"Wang L, Sun X, He J, Liu Z. Functions and molecular mechanisms of Deltex family ubiquitin E3 ligases in development and disease. Front Cell Dev Biology. 2021;9:706997.","journal-title":"Front Cell Dev Biology"},{"key":"4170_CR39","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1126\/scisignal.aag2989","volume":"10","author":"P Chastagner","year":"2017","unstructured":"Chastagner P, Rubinstein E, Brou C. Ligand-activated Notch undergoes DTX4-mediated ubiquitylation and bilateral endocytosis before ADAM10 processing. Sci Signal. 2017;10:483.","journal-title":"Sci Signal"},{"issue":"7","key":"4170_CR40","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1158\/1078-0432.CCR-08-2004","volume":"15","author":"ME Mullendore","year":"2009","unstructured":"Mullendore ME, Koorstra JB, Li YM, Offerhaus GJ, Fan X, Henderson CM, et al. Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Research: Official J Am Association Cancer Res. 2009;15(7):2291\u2013301.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"10","key":"4170_CR41","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41419-024-07110-w","volume":"15","author":"Q Jia","year":"2024","unstructured":"Jia Q, Zhu Y, Yao H, Yin Y, Duan Z, Zheng J, Ma D, Yang M, Yang J, Zhang J, Liu D, Hua R, Huo Y, Fu X, Sun Y, Liu W. Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9\/ NOTCH\/ DDR axis in pancreatic ductal adenocarcinoma. Cell Death Dis. 2024;15(10):767.","journal-title":"Cell Death Dis"},{"issue":"6","key":"4170_CR42","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/01.sla.0000189115.94847.f1","volume":"242","author":"P B\u00fcchler","year":"2005","unstructured":"B\u00fcchler P, Gazdhar A, Schubert M, Giese N, Reber HA, Hines OJ, et al. The Notch signaling pathway is related to neurovascular progression of pancreatic cancer. Ann Surg. 2005;242(6):791\u2013800.","journal-title":"Ann Surg"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04170-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04170-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:04:16Z","timestamp":1770653056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-025-04170-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4170"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04170-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics review board of Yiji Shan Hospital (2023 Ethical Review No. 204) in accordance with the Declaration of Helsinki. All methods were carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from all individual patients included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}